Am J Med Genet B Neuropsychiatr Genet

1. ASTORINO MF, Calabro M, Infortuna C, Muscatello MRA, et al
   The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature.
   Am J Med Genet B Neuropsychiatr Genet. 2025;198:168-189.
   

   >> Share

   
   

   
   Br J Psychiatry

2. DIEDERICH F, Oloyede E, Taylor D, Bachmann CJ, et al
   Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine.
   Br J Psychiatry. 2025 Nov 13:1-8. doi: 10.1192/bjp.2025.10424.
   

   >> Share

   
   
3. HOWES O, Kapi M, Bukala BR
   Does relapse matter? Insights from new data in schizophrenia.
   Br J Psychiatry. 2025 Nov 10:1-3. doi: 10.1192/bjp.2025.10470.
   

   >> Share

   
   

   
   Nat Genet

4. TUBBS JD, Chen Y, Duan R, Huang H, et al
   Real-time dynamic polygenic prediction for streaming data.
   Nat Genet. 2025;57:2863-2871.
   

   >> Share

   
   

   
   Neuropsychopharmacology

5. TARUMI R, Honda S, Cassidy C, Etani T, et al
   Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia.
   Neuropsychopharmacology. 2025 Nov 7. doi: 10.1038/s41386-025-02275.
   

   >> Share

   
   

   
   Psychiatry Res

6. CELIC RUZIC M, Zarkovic N, Rossini Gajsak L, Filipcic I, et al
   Persistent oxidative stress and functional outcomes in early psychosis: A longitudinal study.
   Psychiatry Res. 2025;354:116818.
   

   >> Share

   
   

   
   Schizophr Res

7. SRIHARI VH, Keshavan MS
   Learning health systems for first-episode psychosis: Insights from North America.
   Schizophr Res. 2025 Nov 11:S0920-9964(25)00376.
   

   >> Share

   
   
8. BUCK B, Whiting E, Hallgren K, Monroe-DeVita M, et al
   Pilot randomized controlled trial of Bolster, an mHealth intervention for caregivers to young people with early psychosis.
   Schizophr Res. 2025;286:132-141.
   

   >> Share

   
   
9. YE A, Zhang D, Liu X, Xu L, et al
   Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals.
   Schizophr Res. 2025;285:196-203.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share